Transplant Accommodation in Highly Sensitized Patients: A Potential Role for Bcl-xL and Alloantibody

American Journal of Transplantation

Volumn 1, Issue 3, 2001, Pages 260-269

  Salama, Alan D ^a,b   Delikouras, Alex ^a   Pusey, Charles D ^a   Cook, H Terrance ^a   Bhangal, Gurjeet ^a   Lechler, Robert I ^a   Dorling, Anthony ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Accommodation; Allotransplantation; Anti HLA antibody; Apoptosis; Rejection

Indexed keywords

ALLOANTIBODY; BCL2L1 PROTEIN, HUMAN; HLA ANTIGEN; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN BCL 2; PROTEIN BCL X;

ADULT; ALLOTRANSPLANTATION; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; APOPTOSIS; ARTICLE; BLOOD; CAPILLARY; CYTOTOXICITY; FEMALE; HUMAN; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MALE; METHODOLOGY; PATHOLOGY; TIME; VASCULARIZATION;

ADULT; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; APOPTOSIS; BCL-X PROTEIN; CAPILLARIES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HLA ANTIGENS; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; INTERCELLULAR ADHESION MOLECULE-1; ISOANTIBODIES; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035453191     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2001.001003260.x     Document Type: Article

References (34)

1. Collins AB, Schneeberger EE, Pascual MA et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 2208-2214.
2. Alexandre GP, De Bruyere M, Squifflet JP, Moriau M, Latinne D, Pirson Y. Human ABO-incompatible living donor renal homografts. Neth J Med 1985; 28: 231-234.
3. Palmer A, Taube D, Welsh K, Bewick M, Gjorstrup P, Thick M. Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet 1989; 1: 10-12.
4. Kupin WL, Venkat KK, Hayashi H, Mozes MF, Oh HK, Watt R. Removal of lymphocytotoxic antibodies by pretransplant immunoadsorption therapy in highly sensitized renal transplant recipients. Transplantation 1991; 51: 324-329.
5. Mendez R, Sakhrani L, Aswad S, Minasian R, Obispo E, Mendez RG. Successful living-related ABO incompatible renal transplant using the BIOSYNSORB Immunoadsorption Column. Transplant Proc 1992; 24: 1738-1740.
6. Ross CN, Gaskin G, Gregor Macgregor S et al. Renal transplantation following immunoadsorption in highly sensitized recipients. Transplantation 1993; 55: 785-789.
7. Reisaeter AV, Leivestad T, Albrechtsen D et al. Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients. Transplantation 1995; 60: 242-248.
8. Fischel RJ, Bolman RMD, Platt JL, Najarian JS, Bach FH, Matas AJ. Removal of IgM anti-endothelial antibodies results in prolonged cardiac xenograft survival. Transplant Proc 1990; 22: 1077-1078.
9. Leventhal JR, Sakiyalak P, Witson J et al. The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates. Transplantation 1994; 57: 974-978.
10. Hasan R, Van den Bogaerde J, Forty J, Wright L, Wallwork J, White DJ. Xenograft adaptation is dependent on the presence of antispecies antibody, not prolonged residence in the recipient. Transplant Proc 1992; 24: 531-532.
11. Bach FH, Ferran C, Hechenleitner P et al. Accommodation of vascularized xenografts: expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. Nature Med 1997; 3: 196-204.
12. Charpentier BM, Hiesse C, Kriaa F et al. How to deal with the hyperimmunized potential recipients. Kidney Int 1992; 38(Suppl.): 176-181.
13. Kriaa F, Laurian Y, Hiesse C, Tchernia G, Charpentier B. Five years' experience at one centre with protein A immunoadsorption in patients with deleterious allo/autoantibodies (anti-HLA antibodies, autoimmune bleeding disorders) and post-transplant patients relapsing with focal glomerular sclerosis. Nephrol Dial Transplant 1995; 6: 108-110.
14. Brouard S, Blancho G, Moreau A, Heslan JM, Cuturi MC, Soulillou JP. Long-term survival of hamster-to-rat cardiac xenografts in the absence of a Th2 shift. Transplantation 1998; 65: 1555-1563.
15. Bach FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today 1997; 18: 483-486.
16. Ferran C, Stroka DM, Badrichani AZ et al. A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 1998; 91: 2249-2258.
17. Alexandre GP, Squifflet JP, De Bruyere M et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19: 4538-4542.
18. Dorling A, Stocker C, Tsao T, Haskard DO, Lechler RI. In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies. Transplantation 1996; 62: 1127-1136.
19. Dorling A, Delikouras A, Nohadani M, Polak J, Lechler RI. In vitro accommodation of porcine endothelial cells by low dose human anti-pig antibody: reduced binding of human lymphocytes by accommodated cells associated with increased nitric oxide production. Xenotransplantation 1998; 5: 84-92.
20. Sepp A, Binns RM, Lechler RI. Improved protocol for colorimetric detection of complement-mediated cytotoxicity based on the measurement of cytoplasmic lactate dehydrogenase activity. J Immunol Methods 1996; 196: 175-180.
21. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet 1966; 1: 662-665.
22. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735-739.
23. Dubernard JM, Carpenter CB, Busch GJ, Diethelm AG, Murray JE. Rejection of canine renal allografts by passive transfer of sensitized serum. Surgery 1968; 64: 752-760.
24. Lajoie G. Antibody-mediated rejection of human allografts: an electron microscopic study of peritubular capillaries. Ultrastruct Pathol 1997; 21: 235-242.
25. Platt JL, Vercellotti GM, Dalmasso AP et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11: 450-456.
26. Bach FH, Turman MA, Vercellotti GM, Platt JL, Dalmasso AP. Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant Proc 1991; 23: 205-207.
27. Badrichani AZ, Stroka DM, Bilbao G, Curiel DT, Bach FH, Ferran C. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB. J Clin Invest 1999; 103: 543-553.
28. Cooper DK, Good AHYeY, Koren E et al. Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting. Transplant Proc 1993; 25: 377-378.
29. Nath KA, Balla G, Vercellotti GM et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992; 90: 267-270.
30. Hosenpud JD, Shipley GD, Morris TE, Hefeneider SH, Wagner CR. The modulation of human aortic endothelial cell ICAM-1 (CD-54) expression by serum containing high titers of anti-HLA antibodies. Transplantation 1993; 55: 405-411.
31. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nature Med 1998; 4: 1392-1396.
32. Bian H, Reed EF. Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-γ and TNF-α. J Immunol 1999; 163: 1010-1018.
33. Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89: 2429-2442.
34. Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 1998; 187: 329-339.